Environmental enteric dysfunction, systemic inflammation, growth hormones, and linear growth in infants in western Kenya: a prospective observational cohort study
Targeting young infants with environmental enteric dysfunction, and especially increased gut permeability, may prevent or ameliorate chronic systemic inflammation and improve growth and development in infants in western Kenya. The PROSYNK trial was registered at the Pan African Clinical Trials Registry (https://pactr.samrc.ac.za/) as PACTR202003893276712 (https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=9798).
Authors
- Micah J. June (ORCID: https://orcid.org/0000-0001-9077-842X)
- Feiko O. ter Kuile (ORCID: https://orcid.org/0000-0003-3663-5617)
- Alloys K’Oloo
- James Dodd (ORCID: https://orcid.org/0000-0003-4805-5759)
- Miriam Chomba
- Mary Iwaret Otiti (ORCID: https://orcid.org/0000-0002-5514-6846)
- Stephen Allen (ORCID: https://orcid.org/0000-0001-6675-249X)
- Simon Kariuki
- Duolao Wang (ORCID: https://orcid.org/0000-0003-2788-2464)
- Kephas Otieno
Institutions
- Liverpool School of Tropical Medicine (GB)
- Kenya Medical Research Institute (KE)
Publication Details
- Journal
- American Journal of Clinical Nutrition
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1016/j.ajcnut.2025.10.012
- Primary Topic
- Child Nutrition and Water Access
- Type
- article
- Field-Weighted Citation Impact
- 0.00